デヒドロエピアンドロステロンの減少は,デュタステリド治療を受けている良性前立腺増殖の患者における勃起不全および気分障害の予測因子である
Maja Sofronievska Glavinov1, Senol Tahir2, Stefan Arsov3
1Faculty of Medical Sciences, Goce Delcev University, Stip, North Macedonia Urology Department, University Surgery Hospital St.Naum Ohridski, Skopje, North Macedonia.
American journal of men's health
|August 23, 2025
まとめ
デヒドロエピアンドロステロン硫酸 (DHEAS) 濃度は,ドゥタステリドで治療された良性前立腺増殖 (BPH) の男性における勃起不全 (ED) と気分の変化を予測する. 治療前にDHEASを評価することで,副作用のリスクを減らすことができます.
科学分野:
- 内分泌学
- 泌尿器科
- 神経内分泌学
背景:
- デヒドロエピアンドロステロン硫酸 (DHEAS) の年齢関連の減少は男性ステロイド合成に影響します.
- DHEASは独特のニューロステロイドであり,ドタステリドのような5α還元酵素阻害剤の影響を受けない弱いアンドロゲンです.
- デュタステリドは良性前立腺増殖 (BPH) に使用されますが,勃起不全 (ED) と気分障害を引き起こす可能性があります.
研究 の 目的:
- BPH患者におけるDHEAS値とデュタステリド誘発の副作用 (EDと気分障害) の関係を調査する.
- EDや気分障害の発生や悪化を予測できるかどうかを判断する.
- この関係における年齢の影響を評価する.
主な方法:
- 250人のBPH患者は年齢グループに分けられた (<60歳と≥60歳).
- 患者はタムスロシンまたはタムスロシンとドゥタステリドを6ヶ月間投与された.
- DHEASレベルが測定され,ED/気分障害は標準化されたアンケートで評価されました.
主要な成果:
- デタステリド併用療法を受けた患者におけるDHEAS値と勃起機能および気分状態の相関 (p < .05).
- DHEASは,タムスロシンを受けた高齢患者およびドゥタステリドを受けた両方の年齢層においてEDのポジティブな予測因子であった (p < 0. 001).
- DHEASは,両年齢グループにおける気分変化の有意なマイナスの予測因子であった (p < 0. 001).
結論:
- ドタステリド治療を受けているBPH患者におけるDHEASのベースライン値は,勃起機能と気分の変化を予測することができます.
- デュタステリド治療の前にDHEASの評価を行うことは,EDや気分障害のリスクを軽減するために推奨されます.
- この発見は,BPHおよび関連する副作用の管理におけるDHEASの神経ステロイド作用を強調しています.
関連する概念動画
Disorders of the Male Reproductive System
575
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
575
Menopause
248
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
248
Bone Disorders
3.9K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.9K
Male Sexual Response: Erection & Ejaculation
4.8K
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
4.8K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
248
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
248
Testosterone: Functions and Regulation
1.0K
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
1.0K


